- Pfizer (Groton, CT)
- …the development strategy for programs within our Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)...experience in the phase 2 - 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Hartford, CT)
- …Experience in conducting global clinical trials in both early- and late - stage clinical development, especially protocol development and trial initiation ... study concept to clinical study protocol for both early- and late - stage programs + Leads or joins multi-disciplinary, multi-regional, matrix team through… more
- Sumitomo Pharma (Hartford, CT)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Hartford, CT)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more